This inventor holds 1 USPTO granted patent. Top assignee: Astellas Pharma Gmbh. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Eri Shoda: Innovator in Prokinetic Agent Screening
Introduction
Eri Shoda is a prominent inventor based in Chuo-ku, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of screening methods for prokinetic agents. Her work focuses on addressing diseases associated with abnormalities in 5-HT production and secretion.
Latest Patents
Eri Shoda holds a patent for a screening method aimed at identifying substances that can serve as prophylactic and therapeutic drugs for various digestive organ diseases. This patent, which is particularly relevant for conditions such as constipation type irritable bowel syndrome, functional dyspepsia, and diarrhea, highlights her innovative approach to tackling complex health issues. The patent is a testament to her dedication to improving patient outcomes through scientific research.
Career Highlights
Eri Shoda is currently employed at Astellas Pharma GmbH, where she continues to advance her research in the pharmaceutical industry. Her career is marked by a commitment to innovation and a focus on developing effective treatments for digestive disorders.
Collaborations
Eri has collaborated with notable colleagues, including Katsura Nozawa and Hitoshi Doihara, to further her research initiatives. These collaborations have enhanced her work and contributed to the advancement of knowledge in her field.
Conclusion
Eri Shoda's contributions to the pharmaceutical industry, particularly through her patent on prokinetic agents, underscore her role as an influential inventor. Her work not only addresses critical health challenges but also exemplifies the impact of innovation in medicine.